You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 21 February 2024

Sec. Experimental Pharmacology and Drug Discovery

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1374595

Corrigendum: Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in rats

  • 1. Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

  • 2. Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran

  • 3. Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

  • 4. Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran

  • 5. Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

  • 6. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  • 7. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

  • 8. Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar

Article metrics

View details

1,8k

Views

797

Downloads

In the published article, there was an error in Figure 4A as published. During the last stage of revision, labels in Figure 4A were inadvertently altered, and the group labels in the figure were mistakenly substituted. The corrected Figure 4A appears below:

FIGURE 4

FIGURE 4

Effect of S. minor on the levels of cTn-T, CK-MB, LDH, and CPK after isoproterenol administration. The levels of cTn-T (A), CK-MB (C), CPK (B), and LDH (D) were evaluated in serum. Data were expressed as mean ± SEM. ###p < 0.001 in comparison with the control group. ***p < 0.001 in comparison with isoprenaline (85 mg/kg).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

myocardial infarction, isoprenaline, oxidative stress, cardiotoxicity, herbal medicine, superoxide dismutase

Citation

Hosseini A, Ghorbani A, Sadat Alavi M, Forouhi N, Rajabian A, Boroumand-Noughabi S, Sahebkar A and Eid AH (2024) Corrigendum: Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in rats. Front. Pharmacol. 15:1374595. doi: 10.3389/fphar.2024.1374595

Received

22 January 2024

Accepted

12 February 2024

Published

21 February 2024

Volume

15 - 2024

Edited and reviewed by

Syed Shams Ul Hassan, Shanghai Jiao Tong University, China

Updates

Copyright

*Correspondence: Amirhossein Sahebkar, ; Ali H. Eid,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics